Abstract
In April 2004, telithromycin (Ketek; Aventis), the first of a new class of antibacterial drugs derived from macrolides, was approved by the US FDA for the treatment of several respiratory-tract infections. After a delay in its approval owing to a need to address potential safety issues, is it likely to now attain the blockbuster status that had originally been widely predicted?
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Nilius, A. M. & Ma, Z. Ketolides: the future of the macrolides? Curr. Opin. Pharmacol. 2, 493–500 (2002).
Schlünzen, F. et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413, 814–821 (2001).
Agouridas, C. et al. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens. J. Med. Chem. 41, 4080–4100 (1998).
Denis, A. et al. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Bioorg. Med. Chem. Lett. 9, 3075–3080 (1999).
FDA drug approvals list [online], <http://www.fda.gov/cder/foi/label/2004/21144_ketek_lbl.pdf> (2004).
Reinert, R. R. Clinical efficacy of ketolides in the treatment of respiratory tract infections. J. Antimicrob. Chemother. 53, 918–927 (2004).
World Health Report. 2003. [online], <http://www.who.int/whr/2003/en/> (2003).
Doern, G. V. & Brown, S. D. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01. J. Infect. 48, 56–65 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raja, A., Lebbos, J. & Kirkpatrick, P. Telithromycin. Nat Rev Drug Discov 3, 733–734 (2004). https://doi.org/10.1038/nrd1502
Issue date:
DOI: https://doi.org/10.1038/nrd1502
This article is cited by
-
How Memory Regulates Drug Resistant Pathogenic Bacteria? A Mathematical Study
International Journal of Applied and Computational Mathematics (2017)
-
Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model
The Journal of Antibiotics (2016)
-
Evolution of class C β-lactamases: factors influencing their hydrolysis and recognition mechanisms
Theoretical Chemistry Accounts (2008)
